Therapeutic Asset Ratings

1,537 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
PREDNISONE TABLETS Intravascular Large B-Cell Lymphoma	Northwestern University	P2/3	BB (67)
Quizartinib High Risk Myelodysplastic Syndrome	M.D. Anderson Cancer Center	P2/3	BB (67)
ROPIVACAINE Sternotomy	University of British Columbia	P2/3	BB (67)
Rybelsus Adolescent Obesity	Pfizer	P2/3	BB (67)
Serplulimab Non-small Cell Lung Cancer	Tang-Du Hospital	P2/3	BB (67)
(+)-VINCRISTINE Leukemia	Dana-Farber Cancer Institute	P2/3	BB (67)
VINCRISTINE SULFATE Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma	National Cancer Institute (NCI)	P2/3	BB (67)
VINCRISTINE SULFATE T-Cell/Histiocyte-Rich Large B-Cell Lymphoma	Northwestern University	P2/3	BB (67)
Zorifertinib Central Nervous System (CNS) Metastases	Alpha Biopharma (Jiangsu) Co., Ltd.	P2/3	BB (67)
4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE Mild Cognitive Impairment	Akiva Mintz	P2/3	BB (66)
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs MDS	Fred Hutchinson Cancer Center	P2/3	BB (66)
AMLODIPINE Cognitively Normal Older Adults	Rong Zhang	P2/3	BB (66)
AMLODIPINE Subjective Cognitive Decline	Rong Zhang	P2/3	BB (66)
Atezolizumab Platinum-Resistant Fallopian Tube Carcinoma	Ronald Buckanovich	P2/3	BB (66)
Atezolizumab Platinum-Resistant Primary Peritoneal Carcinoma	Ronald Buckanovich	P2/3	BB (66)
Benadryl Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	Merck Sharp & Dohme LLC	P2/3	BB (66)
Busulphan Sickle Cell Disease	St. Jude Children's Research Hospital	P2/3	BB (66)
Calcium folinate pentahydrate Recurrent Adult Acute Lymphoblastic Leukemia	Shanxi Bethune Hospital	P2/3	BB (66)
Cediranib Fallopian Tube Serous Adenocarcinoma	National Cancer Institute (NCI)	P2/3	BB (66)
Cyclophosphamide Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type	Li Zhiming	P2/3	BB (66)
Cyclophosphamide Intravascular Large B-Cell Lymphoma	Mayo Clinic	P2/3	BB (66)
Cyclophosphamide Mature B-Cell Lymphoma	BeOne Medicines	P2/3	BB (66)
Cyclophosphamide Thalassemia	Memorial Sloan Kettering Cancer Center	P2/3	BB (66)
Cytosin-Arabinosid Acute Leukemia	Janssen Research & Development, LLC	P2/3	BB (66)
Eloxatin C04.588.274.476.411.307	Chung Shan Medical University	P2/3	BB (66)

Showing 126 to 150 of 1,537 assets

PreviousPage 6 of 62Next